09.07 22:05 | dpa-AFX: GNW-News: Inventiva names Jason Campagna as President of R&D and Chief Medical Officer and Martine Zimmermann as Executive Vice President of Regulatory Affairs and Quality Assurance |
09.07 22:05 | dpa-AFX: GNW-News: Inventiva names Jason Campagna as President of R&D and Chief Medical Officer and Martine Zimmermann as Executive Vice President of Regulatory Affairs and Quality Assurance |
07.07 22:00 | dpa-AFX: GNW-News: Inventiva receives $10 million milestone payment from CTTQ |
07.07 22:00 | dpa-AFX: GNW-News: Inventiva receives $10 million milestone payment from CTTQ |
02.07 22:00 | dpa-AFX: GNW-News: Inventiva announces the publication in Journal of Hepatology Reports on results of lanifibranor treatment on liver sinusoidal endothelial cells in patients with MASLD/MASH and in preclinical models of the disease |
02.07 22:00 | dpa-AFX: GNW-News: Inventiva announces the publication in Journal of Hepatology Reports on results of lanifibranor treatment on liver sinusoidal endothelial cells in patients with MASLD/MASH and in preclinical models of the disease |
10.06 22:00 | dpa-AFX: GNW-News: Inventiva Announces the Appointment of Renée Aguiar-Lucander to its Board of Directors |
10.06 22:00 | dpa-AFX: GNW-News: Inventiva Announces the Appointment of Renée Aguiar-Lucander to its Board of Directors |
27.05 22:00 | dpa-AFX: GNW-News: Inventiva to Participate in the Upcoming Jefferies Global Healthcare Conference and UBS Spring Biotech Conference |
27.05 22:00 | dpa-AFX: GNW-News: Inventiva to Participate in the Upcoming Jefferies Global Healthcare Conference and UBS Spring Biotech Conference |
23.05 08:30 | dpa-AFX: GNW-News: Inventiva reports 2025 First Quarter Financial Information¹ |
23.05 08:30 | dpa-AFX: GNW-News: Inventiva reports 2025 First Quarter Financial Information¹ |
23.05 08:00 | dpa-AFX: GNW-News: Results of the Votes of the Combined Shareholders' General Meeting of May 22, 2025 |
23.05 08:00 | dpa-AFX: GNW-News: Results of the Votes of the Combined Shareholders' General Meeting of May 22, 2025 |
22.05 14:00 | dpa-AFX: GNW-News: Description of the Share Repurchase Program Covered by the Liquidity Agreement with Kepler Chevreux |
22.05 14:00 | dpa-AFX: GNW-News: Description of the Share Repurchase Program Covered by the Liquidity Agreement with Kepler Chevreux |
05.05 08:30 | dpa-AFX: GNW-News: Inventiva secures the ?116 million second tranche of its structured financing of up to ?348 million |
05.05 08:30 | dpa-AFX: GNW-News: Inventiva secures the ?116 million second tranche of its structured financing of up to ?348 million |
30.04 22:00 | dpa-AFX: GNW-News: Combined General Meeting of May 22, 2025 - Availability of the preparatory documents |
30.04 22:00 | dpa-AFX: GNW-News: Statement of total voting rights and shares forming the company's share capital as of April 11, 2025 |
|